These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34046603)

  • 81. Apigenin analogues as SARS-CoV-2 main protease inhibitors:
    Farhat A; Ben Hlima H; Khemakhem B; Ben Halima Y; Michaud P; Abdelkafi S; Fendri I
    Bioengineered; 2022 Feb; 13(2):3350-3361. PubMed ID: 35048792
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacophore model-aided virtual screening combined with comparative molecular docking and molecular dynamics for identification of marine natural products as SARS-CoV-2 papain-like protease inhibitors.
    Thangavel N; Albratty M
    Arab J Chem; 2022 Dec; 15(12):104334. PubMed ID: 36246784
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Combining virtual screening with cis-/trans-cleavage enzymatic assays effectively reveals broad-spectrum inhibitors that target the main proteases of SARS-CoV-2 and MERS-CoV.
    Chang YJ; Le UNP; Liu JJ; Li SR; Chao ST; Lai HC; Lin YF; Hsu KC; Lu CH; Lin CW
    Antiviral Res; 2023 Aug; 216():105653. PubMed ID: 37321487
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Development of a Novel Pharmacophore Model Guided by the Ensemble of Waters and Small Molecule Fragments Bound to SARS-CoV-2 Main Protease.
    Kumar P; Mohanty D
    Mol Inform; 2022 Feb; 41(2):e2100178. PubMed ID: 34633768
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease.
    Andrianov AM; Kornoushenko YV; Karpenko AD; Bosko IP; Tuzikov AV
    J Biomol Struct Dyn; 2021 Sep; 39(15):5779-5791. PubMed ID: 32662333
    [TBL] [Abstract][Full Text] [Related]  

  • 86. An Updated Review on SARS-CoV-2 Main Proteinase (M
    Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
    Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Computational guided identification of potential leads from
    Zothantluanga JH; Gogoi N; Shakya A; Chetia D; Lalthanzara H
    Futur J Pharm Sci; 2021; 7(1):201. PubMed ID: 34660817
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity.
    Weng YL; Naik SR; Dingelstad N; Lugo MR; Kalyaanamoorthy S; Ganesan A
    Sci Rep; 2021 Apr; 11(1):7429. PubMed ID: 33795718
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
    Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D
    J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cordifolioside: potent inhibitor against M
    Manne M; Goudar G; Varikasuvu SR; Khetagoudar MC; Kanipakam H; Natarajan P; Ummiti MD; Yenagi VA; Chinthakindi S; Dharani P; Thota DSS; Patil S; Patil V
    3 Biotech; 2021 Mar; 11(3):136. PubMed ID: 33643762
    [TBL] [Abstract][Full Text] [Related]  

  • 92. An Analysis of Successful Hit-to-Clinical Candidate Pairs.
    Brown DG
    J Med Chem; 2023 Jun; 66(11):7101-7139. PubMed ID: 37224022
    [TBL] [Abstract][Full Text] [Related]  

  • 93. On the origins of SARS-CoV-2 main protease inhibitors.
    Janin YL
    RSC Med Chem; 2024 Jan; 15(1):81-118. PubMed ID: 38283212
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review.
    Li X; Song Y
    Eur J Med Chem; 2023 Nov; 260():115772. PubMed ID: 37659195
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro.
    Ruatta SM; Prada Gori DN; Fló Díaz M; Lorenzelli F; Perelmuter K; Alberca LN; Bellera CL; Medeiros A; López GV; Ingold M; Porcal W; Dibello E; Ihnatenko I; Kunick C; Incerti M; Luzardo M; Colobbio M; Ramos JC; Manta E; Minini L; Lavaggi ML; Hernández P; Šarlauskas J; Huerta García CS; Castillo R; Hernández-Campos A; Ribaudo G; Zagotto G; Carlucci R; Medrán NS; Labadie GR; Martinez-Amezaga M; Delpiccolo CML; Mata EG; Scarone L; Posada L; Serra G; Calogeropoulou T; Prousis K; Detsi A; Cabrera M; Alvarez G; Aicardo A; Araújo V; Chavarría C; Mašič LP; Gantner ME; Llanos MA; Rodríguez S; Gavernet L; Park S; Heo J; Lee H; Paul Park KH; Bollati-Fogolín M; Pritsch O; Shum D; Talevi A; Comini MA
    Front Pharmacol; 2023; 14():1193282. PubMed ID: 37426813
    [No Abstract]   [Full Text] [Related]  

  • 96. Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.
    Gao K; Wang R; Chen J; Cheng L; Frishcosy J; Huzumi Y; Qiu Y; Schluckbier T; Wei X; Wei GW
    Chem Rev; 2022 Jul; 122(13):11287-11368. PubMed ID: 35594413
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Targeting the BspC-vimentin interaction to develop anti-virulence therapies during Group B streptococcal meningitis.
    Manzer HS; Villarreal RI; Doran KS
    PLoS Pathog; 2022 Mar; 18(3):e1010397. PubMed ID: 35316308
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules.
    Gentile F; Fernandez M; Ban F; Ton AT; Mslati H; Perez CF; Leblanc E; Yaacoub JC; Gleave J; Stern A; Wong B; Jean F; Strynadka N; Cherkasov A
    Chem Sci; 2021 Dec; 12(48):15960-15974. PubMed ID: 35024120
    [TBL] [Abstract][Full Text] [Related]  

  • 99. An overview of potential inhibitors targeting non-structural proteins 3 (PL
    Yan F; Gao F
    Comput Struct Biotechnol J; 2021; 19():4868-4883. PubMed ID: 34457214
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease.
    Mengist HM; Dilnessa T; Jin T
    Front Chem; 2021; 9():622898. PubMed ID: 33889562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.